MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,801.77
-0.22%
NASDAQ 100
$31,160.08
-0.21%
DOW JONES
$51,180.00
-0.66%
NASDAQ Composite
$27,538.69
-0.22%
RUSSELL 2000
$2,777.00
-1.29%
CBOE VIX
$15.08
+0.47%
Sector Heatmap
Technology-0.30%
Financials-0.48%
Healthcare+1.03%
Consumer Cycl-0.32%
Consumer Staples-0.12%
Energy-0.58%
Industrials-2.18%
Materials-1.51%
Real Estate-1.29%
Utilities-0.02%
Comm Services-0.35%
PEN — Penumbra, Inc.
NYSEPenumbra, Inc.
$316.35
-0.70(-0.22%)
- O
- 316.62
- H
- 317.74
- L
- 316.32
- V
- 363.84K
⏱️ End-of-day dataAs of Oct 7, 2026
Chart
About PEN
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
SectorNot available
IPO DateSep 18, 2015
Employees4,700
Stock ExchangeNYSE
Ticker SymbolPEN
Websitehttps://www.penumbrainc.com
Key Financial Statistics
| Market Cap | $12.51B |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $221.26 - $362.41 |
| 52-Week Avg Volume | 566.2K |
| VWAP | $317.09 |
| Transactions | 12,587 |
| Total Recorded Bars | 2,779 days |